Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 1, 2008, Pages 12-23

  Genovese, Tiziana ^a   Esposito, Emanuela ^a,b   Mazzon, Emanuela ^a   Di Paola, Rosanna ^a   Meli, Rosaria ^b   Bramanti, Placido ^a   Piomelli, Daniele ^c,d   Calignano, Antonio ^b   Cuzzocrea, Salvatore ^a,e  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CYTOKINE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLIP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFECT; DURA MATER; EDEMA; ENZYME ACTIVITY; INJURY SEVERITY; LAMINECTOMY; MALE; MOUSE; MYELITIS; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; TISSUE INJURY; VERTEBRA; WESTERN BLOTTING;

ANIMALS; MALE; MICE; MOTOR SKILLS; NITRIC OXIDE SYNTHASE TYPE II; PALMITIC ACIDS; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 45749149121     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.136903     Document Type: Article

References (53)

1. Ackery A, Robins S, and Fehlings MG (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 23:604-616.
2. Anderson DK and Hall ED (1993) Pathophysiology of spinal cord trauma. Ann Emerg Med 22:987-992.
3. Astarita G, Di Giacomo B, Gaetani S, Oveisi F, Compton TR, Rivara S, Tarzia G, Mor M, and Piomelli D (2006) Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties. J Pharmacol Exp Ther 318:563-570.
4. Bao F, DeWitt DS, Prough DS, and Liu D (2003) Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 71:220-227.
5. Bar-Peled O, Knudson M, Korsmeyer SJ, and Rothstein JD (1999) Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J Neurosci Res 55:542-556.
6. Basso DM, Beattie MS, and Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
7. Beattie MS, Farooqui AA, and Bresnahan JC (2000) Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 17:915-925.
8. Beattie MS, Hermann GE, Rogers RC, and Bresnahan JC (2002) Cell death in models of spinal cord injury. Prog Brain Res 137:37-47.
9. Benani A, Kremarik-Bouillaud P, Bianchi A, Netter P, Minn A, and Dauca M (2003) Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord. J Chem Neuroanat 25:29-38.
10. Berdyshev E, Boichot E, Corbel M, Germain N, and Lagente V (1998) Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 63:PL125-PL129.
11. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, and Yezierski RP (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18:3251-3260.
12. Blight AR (1992) Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 9 (Suppl 1):S83-S91.
13. Bowie A and O'Neill LA (2000) Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23.
14. Bregman BS, Broude E, McAtee M, and Kelley MS (1998) Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp Neurol 149:13-27.
15. Calignano A, La Rana G, Giuffrida A, and Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277-281.
16. Casha S, Yu WR, and Fehlings MG (2001) Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203-218.
17. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, and Guild BC (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
18. Costa B, Conti S, Giagnoni G, and Colleoni M (2002) Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br J Pharmacol 137:413-420.
19. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, and Caputi AP (2004) Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest 84:1643-1654.
20. Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Min W, Di Paola R, Muia C, Li JH, Esposito E, Bramanti P, et al. (2006) Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J Pharmacol Exp Ther 319:127-138.
21. Cuzzocrea S, Riley DP, Caputi AP, and Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharm Rev 53:135-159.
22. Desvergne B and Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688.
23. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
24. Dosreis GA, Borges VM, and Zin WA (2004) The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8:285-293.
25. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
26. Farquhar-Smith WP, Jaggar SI, and Rice AS (2002) Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 97:11-21.
27. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Bramanti P, and Cuzzocrea S (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316:1006-1016.
28. Genovese T, Mazzon E, Di Paola R, Cannavo G, Muia C, Bramanti P, and Cuzzocrea S (2005) Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194:267-278.
29. Glaser J, Gonzalez R, Sadr E, and Keirstead HS (2006) Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 84:724-734.
30. Haddad JJ (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14:879-897.
31. Inoue I, Hayashi K, Yagasaki F, Nakamura K, Matsunaga T, Xu H, Inukai K, Awata T, Komoda T, and Katayama S (2003) Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor gamma 1 (PPAR-gamma 1) and PPARalpha genes. J Atheroscler Thromb 10:99-108.
32. Joshi M and Fehlings MG (2002a) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: I. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19:175-190.
33. Joshi M and Fehlings MG (2002b) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: II. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 19:191-203.
34. Kahlich R, Klima J, Cihla F, Frankova V, Masek K, Rosicky M, Matousek F, and Bruthans J (1979) Studies on prophylactic efficacy of N-2- hydroxyethyl palmitamide (Impulsin) in acute respiratory infections: serologically controlled field trials. J Hyg Epidemiol Microbiol Immunol 23:11-24.
35. Lambert DM, Vandevoorde S, Diependaele G, Govaerts SJ, and Robert AR (2001) Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 42:321-327.
36. La Rosa G, Cardali S, Genovese T, Conti A, Di Paola R, La Torre D, Cacciola F, and Cuzzocrea S (2004) Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J Neurosurg Spine 1:311-321.
37. Long DA and Martin AJ (1956) Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guinea pigs. Lancet 270:464-466.
38. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, and Piomelli D (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67:15-19.
39. Maegele M, Riess P, Sauerland S, Bouillon B, Hess S, McIntosh TK, Mautes A, Brockmann M, Koebke J, Knifka J, et al. (2005) Characterization of a new rat model of experimental combined neurotrauma. Shock 23:476-481.
40. Moreno S, Farioli-Vecchioli S, and Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123:131-145.
41. Mullane K (1989) Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 301:39-51.
42. Murphy GJ and Holder JC (2000) PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 21:469-474.
43. Nesic-Taylor O, Cittelly D, Ye Z, Xu GY, Unabia G, Lee JC, Svrakic NM, Liu XH, Youle RJ, Wood TG, et al. (2005) Exogenous Bcl-xL fusion protein spares neurons after spinal cord injury. J Neurosci Res 79:628-637.
44. Ohkawa H, Ohishi N, and Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
45. Perlík F, Raskova H, and Elis J (1971) Anti-inflammatory properties of N(2-hydroxyethyl) palmitamide. Acta Physiol Acad Sci Hung 39:395-400.
46. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, and Petratos S (2004) Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15:415-436.
47. Rivlin AS and Tator CH (1978) Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10:38-43.
48. Roberts RA, James NH, Woodyatt NJ, Macdonald N, and Tugwood JD (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis 19:43-48.
49. Ross RA, Brockie HC, and Pertwee RG (2000) Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur J Pharmacol 401:121-130.
50. Shea TB (1994) Technical report: an inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. Biotechniques 16:1126-1128.
51. Sirin BH, Ortac R, Cerrahoglu M, Saribulbul O, Baltalarli A, Celebisoy N, Iskesen I, and Rendeci O (2002) Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol 57:279-285.
52. Verma IM (2004) Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann Rheum Dis 63 (Suppl 2):ii57-ii61.
53. Wayman N, McDonald MC, Thompson AS, Threadgill MD, and Thiemermann C (2001) 5-Aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 430:93-100.